Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF
Author(s): Domingo Figal Added: 11 months ago
ESC-HFA 2023 — Prof Domingo Pascual Figal (Hospital Clinico Universitario Virgen de la Arrixaca, SP) discusses the DAPA MODA study (NCT04707352). The study aimed to assess the effects of dapagliflozin on cardiac remodeling parameters, particularly LA geometry and function, and biomarkers reflecting pathophysiological pathways. Findings from ESC Heart Failure 2023 revealed that dapagliflozin… View more

Heart Failure
Simvastatin is Independently Improving Uremic Cardiomyopathy Through Intercommunication Between Macrophage and Cardiomyocyte in Renal Failure Model
Author(s): Barinda Agian Jeffilano , Wawaimuli Arozal , Ulfa Tri Wahyuni , et al Added: 2 years ago

Prevention & Chronic Conditions
Effect of Ventricular Unloading on Heart Recovery
Author(s): Carsten Tschöpe Added: 1 year ago

Heart Failure

Intervention
Research Area(s) / Expertise:

Expertise

MI/ACS
Job title: MD Washington University School of Medicine, St Louis, MO, US
Dr Mann is the Lewin Chair and Professor of Medicine, Cell Biology and Physiology, at the Washington University School of Medicine, and Cardiologist-in-chief at Barnes Jewish Hospital in St Louis, Missouri, US. His research focus has been the molecular and cellular basis of heart failure, with particular emphasis on the role of innate immunity in disease progression and recovery of the failing… View more
Job title: Consultant Cardiologist
Dr Henry J Dargie is Consultant Cardiologist at Western Infirmary, Glasgow, and Director of the National Advanced Heart Failure Service, Glasgow (1980-2010) Research Achievements Metolozone in renal failure and heart failure Total Body Potassium in heart and renal failure Early work on role of SNS in hypertension Early RCT work on role of captopril in HF LVH and ventricular arrhythmias… View more
Plenary Lecture: The Role of Haemodynamic Load in Left Ventricular Remodelling and Reverse Remodelling
Author(s): Douglas L Mann Added: 4 years ago

MI/ACS
Iron Deficiency and Heart Failure
Author(s): Pieter Martens Added: 2 years ago

Standards & Guidelines

Heart Failure
T1 and T2 Mapping in Uremic Cardiomyopathy: An Update
Author(s): Luca Arcari , Giovanni Camastra , Federica Ciolina , et al Added: 2 years ago

Imaging & Diagnostics
HFA 23: Trientine-HCL for Treatment of HFrEF
Author(s): James L Januzzi , Harriette Van Spall Added: 10 months ago
ESC-HFA 2023 - Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss the findings of the TRACER-HF trial. Trientine-HCL is an oral chelation agent. Preclinical trials suggest that this promotes a reverse cardiac remodelling effect in HFrEF patients. 200 patients with New York Heart Association Class II or… View more

Heart Failure